BOCA RATON, Fla., Nov. 15, 2012 (GLOBE NEWSWIRE) -- RxStrategies, Inc. is pleased to announce the appointment of Mary Ellen England to the position of Vice President, Sales and Marketing. England joins RxStrategies with acknowledged industry leadership and extensive experience in market facing roles and expertise to the 340B market. In this new role, England joins the senior leadership team and has primary responsibility for the marketing and delivery of customized 340B pharmacy solutions to the growing 340B marketplace.
"I am very pleased to welcome Mary Ellen to the RxStrategies' leadership team," said Fenton Markevich, Chief Executive Officer for RxStrategies. "We look forward to incorporating her expertise and knowledge for the benefit of our existing and future clients."
"RxStrategies has a strong reputation in the marketplace with a unique and transparent processing solution for this complex market," said England. "I am excited to join a growing industry leader while continuing to further develop and deliver the most effective 340B program in the industry."
Prior to joining RxStrategies, England worked as Director of Education and Marketing for Apexus, Inc.. In this role, England was a recognized industry leader and frequent speaker and panelist at 340B industry conferences. In addition, England also provided oversight and support to Apexus' 340B training and certification initiatives as well as direction and oversight in other operations areas.
About RxStrategies, Inc.
Established in 2003 and headquartered in Boca Raton, Florida, RxStrategies, Inc. provides accountability, transparency and value-based solutions for the Federal 340B Drug Pricing Programs. As a full-service pharmaceutical services organization, they provide a diverse range of services to all "Qualified Entities" and the in-house and/or contract pharmacies, including "real-time" comprehensive solutions to the challenges of regulatory compliance, patient eligibility, pharmacy replenishment, program tracking and reporting of the Federal 340B Drug Pricing Program. To learn more, please visit www.340Bplus.com.
The RxStrategies, Inc. logo is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=15796
